Literature DB >> 21431706

Detection of microRNAs in prostate cancer cells by microRNA array.

Xiaoqing Tang1, Xiaohu Tang, Jozsef Gal, Natasha Kyprianou, Haining Zhu, Guiliang Tang.   

Abstract

MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that regulate gene expression at the posttranscriptional level and play a critical role in many important biological processes and pathological development. In the past few years, miRNAs have been implicated to play an important role in cancer initiation and development. In this chapter, we describe a protocol for the analysis and characterization of miRNAs in prostate cancer cells using a simple but effective array platform. The array is composed of 553 nonredundant miRNAs encompassing the entire set of known miRNAs in humans and mice. As an example, profiling of miRNAs in four prostate cancer cell lines has revealed that a set of miRNAs were differentially expressed between androgen-dependent and androgen-independent metastatic prostate cancer cells. Among them, the differential expression of miR-205 and miR-200c were further validated by Northern blot analysis in these two types of prostate cancer cells. This comprehensive and easy-to-follow protocol will be useful for studying miRNAs in various cancers and can be readily adapted for miRNA analysis in a variety of human diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431706     DOI: 10.1007/978-1-61779-083-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Regulation of microRNA expression and function by nuclear receptor signaling.

Authors:  Zhihong Yang; Li Wang
Journal:  Cell Biosci       Date:  2011-09-21       Impact factor: 7.133

2.  Epigenetic regulation of prostate cancer.

Authors:  Suyin P Chin; Joanne L Dickinson; Adele F Holloway
Journal:  Clin Epigenetics       Date:  2011-06-14       Impact factor: 6.551

3.  The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.

Authors:  Huifen Li; Weihua Huang; Rongcheng Luo
Journal:  Diagn Pathol       Date:  2015-07-22       Impact factor: 2.644

4.  Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.

Authors:  Jin Zhu; Sugui Wang; Wenyu Zhang; Junyi Qiu; Yuxi Shan; Dongrong Yang; Bairong Shen
Journal:  Oncotarget       Date:  2015-12-22

5.  Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration.

Authors:  Hanbing Xie; Ling Nie; Mengni Zhang; Zhengzheng Su; Xueqin Chen; Miao Xu; Jing Gong; Ni Chen; Qiao Zhou
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

Review 6.  Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis.

Authors:  Julia Jansen; Thomas Greither; Hermann M Behre
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

7.  miRNA expression profile analysis in kidney of different porcine breeds.

Authors:  Oriol Timoneda; Ingrid Balcells; Jose Ignacio Núñez; Raquel Egea; Gonzalo Vera; Anna Castelló; Anna Tomàs; Armand Sánchez
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.

Authors:  Eun Ah Shin; Eun Jung Sohn; Gunho Won; Jeong-Un Choi; Myongsuk Jeong; Bonglee Kim; Min-Jeong Kim; Sung-Hoon Kim
Journal:  Oncotarget       Date:  2014-07-30

9.  Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling.

Authors:  Xinghua Zhang; Xiaoli Yao; Cong Qin; Pengcheng Luo; Jie Zhang
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

10.  MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.

Authors:  Xin-Min Zheng; Peng Zhang; Man-Hua Liu; Ping Chen; Wei-Bing Zhang
Journal:  Int J Oncol       Date:  2018-11-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.